Session Type
Meeting
Search Results for Pneumonia
Abstract Number: 275
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Approximately 1-2% of the U.S. population gets community-acquired pneumonia (CAP) annually in the U.S. and CAP is associated with substantial mortality, morbidity and costs. While the incidence of CAP is well-defined, the incidence of outpatients who fail antibiotics and eventually become hospitalized is less clear. The objective of this study was to provide real-world […]
Abstract Number: 281
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Inappropriate antibiotic use is associated with bacterial resistance, adverse events, and an increased risk of Clostridium difficileinfection. However, providers often prescribe antibiotics for viral respiratory infections and treat infections such as bacterial pneumonia for unnecessarily prolonged durations. Serum procalcitonin (PCT)-guided treatment is known to safely reduce antibiotic use and duration of treatment in pneumonia. […]
Abstract Number: 282
Hospital Medicine 2020, Virtual Competition
Background: Pneumocystis jirovecii pneumonia (PJP) is an opportunistic infection associated with lymphopenic conditions including HIV/AIDS, hematologic malignancy1, organ transplantation2, and lymphocyte-suppressive therapies such as high dose glucocorticoids3,4. PJP prophylaxis, which is highly effective, is indicated when the incidence of PJP exceeds the rate of adverse events due to prophylaxis.4,7 Guidelines from the American Thoracic Society […]
Abstract Number: 305
Hospital Medicine 2020, Virtual Competition
Background: In an effort to improve the design of future noninferiority studies, the endpoints for registrational trials of antimicrobials for the treatment of community-acquired bacterial pneumonia (CABP) were recently updated [1]. Lefamulin (LEF) is a first-in-class systemic pleuromutilin antibiotic newly approved for the treatment of adults with CABP [2]. The efficacy of LEF was demonstrated […]
Abstract Number: 312
SHM Converge 2024
Background: Sepsis is one of the most common life-threatening conditions and is associated with significant mortality, length of stay, and cost for hospitals and health systems worldwide. Based on a recent report, there has been an increase in rates of hospital-acquired sepsis (HAS), or sepsis “not-present-on-admission”, in California from 2020 to 2021. Aspiration pneumonia was […]
Abstract Number: 325
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Case Presentation: An 80 year-old man presented with one day of confusion, worsened cough, and subjective fevers. He had a productive cough since emigrating from Mexico six months ago, but no complaints of dyspnea. He had a history of diabetes and stable angina for the past year. On presentation, he was tachycardic with a temperature […]
Abstract Number: 336
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Pneumonia readmission rates are publicly reported and included as quality indicators in Medicare Value-Based Purchasing programs. The Yale New Haven Readmission Risk Score (YNHRRS) for Pneumonia is a tool that uses 25 variables including age, co-morbidities, and vital signs to predict readmission. Functional status and social support were not included in the YNHRRS, despite […]
Abstract Number: 339
Hospital Medicine 2020, Virtual Competition
Background: Asthma, bronchiolitis, and pneumonia are common pediatric inpatient diagnoses. Viral testing (VT) is not routinely necessary for these diagnoses as it often does not impact management. Our study objectives for each diagnosis are to; 1) describe trends in VT over the last 5 years including seasonal variation (respiratory season- Oct-March versus non-respiratory season- April-Sept), […]
Abstract Number: 356
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Case Presentation: Klebsiella Pneumoniae is a gram-negative bacterium known to cause pneumonia and urinary tract infections. The hypermucoviscosity phenotype of K. pneumoniae is commonly tested for using the string test. Clinical studies have shown an association between the hypermucoviscosity phenotype and a highly virulent tissue abscess syndrome, causing liver abscesses, endophthalmitis and septic thrombophlebitis. Most […]
Abstract Number: 356
SHM Converge 2023
Background: The CDC recognizes antimicrobial resistance as an urgent global public health threat and supports antibiotic stewardship initiatives to combat antibiotic resistance. Pneumonia is a frequent condition treated by both hospitalists and emergency room physicians and the most common reason for inpatient antibiotic use and over prescribing. Recent IDSA guidelines for the treatment of community […]